Notice: This company has been marked as potentially delisted and may not be actively trading. Neuralstem (CUR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CUR vs. CELZ, AIM, ONVO, FRTX, ALBT, TTNP, GENE, CERO, EVAX, and PALIShould you be buying Neuralstem stock or one of its competitors? The main competitors of Neuralstem include Creative Medical Technology (CELZ), AIM ImmunoTech (AIM), Organovo (ONVO), Fresh Tracks Therapeutics (FRTX), Avalon GloboCare (ALBT), Titan Pharmaceuticals (TTNP), Genetic Technologies (GENE), CERo Therapeutics (CERO), Evaxion Biotech A/S (EVAX), and Palisade Bio (PALI). These companies are all part of the "medical" sector. Neuralstem vs. Creative Medical Technology AIM ImmunoTech Organovo Fresh Tracks Therapeutics Avalon GloboCare Titan Pharmaceuticals Genetic Technologies CERo Therapeutics Evaxion Biotech A/S Palisade Bio Creative Medical Technology (NASDAQ:CELZ) and Neuralstem (NASDAQ:CUR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking. Do insiders and institutionals hold more shares of CELZ or CUR? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 38.3% of Neuralstem shares are held by institutional investors. 2.8% of Creative Medical Technology shares are held by company insiders. Comparatively, 5.4% of Neuralstem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is CELZ or CUR more profitable? Creative Medical Technology has a net margin of 0.00% compared to Neuralstem's net margin of -39,417.64%. Creative Medical Technology's return on equity of -63.05% beat Neuralstem's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -63.05% -60.42% Neuralstem -39,417.64%-170.51%-110.16% Does the MarketBeat Community favor CELZ or CUR? Neuralstem received 207 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.93% of users gave Creative Medical Technology an outperform vote while only 66.83% of users gave Neuralstem an outperform vote. CompanyUnderperformOutperformCreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% NeuralstemOutperform Votes27866.83% Underperform Votes13833.17% Which has more volatility & risk, CELZ or CUR? Creative Medical Technology has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Neuralstem has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Which has preferable earnings and valuation, CELZ or CUR? Neuralstem has higher revenue and earnings than Creative Medical Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K945.00-$5.29M-$3.80-1.42Neuralstem$260K7.62-$4.93MN/AN/A Does the media favor CELZ or CUR? In the previous week, Creative Medical Technology had 3 more articles in the media than Neuralstem. MarketBeat recorded 3 mentions for Creative Medical Technology and 0 mentions for Neuralstem. Neuralstem's average media sentiment score of 0.00 beat Creative Medical Technology's score of -0.67 indicating that Neuralstem is being referred to more favorably in the news media. Company Overall Sentiment Creative Medical Technology Negative Neuralstem Neutral SummaryCreative Medical Technology beats Neuralstem on 7 of the 13 factors compared between the two stocks. Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUR vs. The Competition Export to ExcelMetricNeuralstemBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.98M$3.11B$5.82B$9.13BDividend YieldN/A1.55%4.75%3.85%P/E RatioN/A30.1126.8119.20Price / Sales7.62330.64434.5471.83Price / CashN/A168.8738.0134.83Price / Book0.143.687.644.62Net Income-$4.93M-$71.72M$3.19B$246.06M Neuralstem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CURNeuralstemN/A$0.94-3.8%N/A+123.2%$1.98M$260,000.000.006CELZCreative Medical Technology0.8907 of 5 stars$4.74+3.3%N/A+28.6%$8.30M$10,000.00-1.255Gap DownHigh Trading VolumeAIMAIM ImmunoTech1.741 of 5 stars$0.13-6.9%$2.75+2,031.8%-66.2%$8.23M$200,000.00-0.2720High Trading VolumeONVOOrganovo1.4745 of 5 stars$0.39+2.1%N/A-63.5%$5.93M$110,000.00-0.3620Earnings ReportAnalyst ForecastFRTXFresh Tracks TherapeuticsN/A$0.93-0.3%N/A+1.1%$5.55M$8.01M-0.6620ALBTAvalon GloboCare1.0054 of 5 stars$3.69-0.8%N/A-3.6%$4.02M$1.26M-0.185News CoverageGap UpTTNPTitan Pharmaceuticals0.3803 of 5 stars$4.03-0.7%N/A-53.6%$3.67M$180,000.000.0010Analyst ForecastNews CoverageGap DownGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeCEROCERo TherapeuticsN/A$2.06+14.4%N/A-99.4%$3.09MN/A0.008Gap DownEVAXEvaxion Biotech A/S2.0352 of 5 stars$2.49-4.6%$20.00+703.2%-86.8%$2.91M$70,000.00-1.7260Analyst ForecastPALIPalisade Bio2.3611 of 5 stars$1.04+1.0%$23.00+2,111.5%-85.1%$2.88M$250,000.00-0.0710News Coverage Related Companies and Tools Related Companies CELZ Alternatives AIM Alternatives ONVO Alternatives FRTX Alternatives ALBT Alternatives TTNP Alternatives GENE Alternatives CERO Alternatives EVAX Alternatives PALI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CUR) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuralstem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
